Detalhe da pesquisa
1.
Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome.
Rheumatology (Oxford);
63(SI): SI54-SI63, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38320587
2.
Can complement activation be the missing link in antiphospholipid syndrome?
Rheumatology (Oxford);
2024 Mar 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38483257
3.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology (Oxford);
63(3): 772-779, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37307082
4.
Sleep-wake behavior, perceived fatigability, and cognitive reserve in older adults.
Alzheimers Dement;
2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38690777
5.
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Lab Invest;
103(6): 100147, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37044248
6.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis;
82(10): 1258-1270, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37640450
7.
How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Blood;
137(3): 299-309, 2021 01 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32898856
8.
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.
Clin Exp Rheumatol;
41(3): 605-612, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35819804
9.
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
Lupus;
31(12): 1485-1490, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36074077
10.
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review.
Lupus;
31(1): 5-18, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34866492
11.
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Lupus;
31(14): 1770-1776, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36206383
12.
Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and duration.
Br J Neurosurg;
36(3): 407-414, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35445634
13.
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
Stroke;
52(1): 91-99, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33280548
14.
Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.
Rheumatology (Oxford);
61(1): 24-41, 2021 12 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34003972
15.
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology (Oxford);
60(3): 1376-1386, 2021 03 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32964932
16.
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.
J Neurol Neurosurg Psychiatry;
2021 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33741739
17.
Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
Lupus;
30(9): 1502-1508, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34192956
18.
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Lupus;
30(14): 2276-2285, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34915764
19.
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
Curr Rheumatol Rep;
23(6): 45, 2021 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33932165
20.
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology (Oxford);
59(7): 1489-1494, 2020 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32359070